Moleac Overview

  • Founded
  • 2002
  • Status
  • Private
  • Employees
  • 15
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3.5M
Latest Deal Amount
  • Investors
  • 1

Moleac General Information


Developer of neurological drugs designed to offer treatment for nerve-related diseases. The company's drug addresses the unmet needs of patients suffering a loss of brain functions after brain injuries or neurodegenerative diseases, enabling patients to recover quickly from the brain and neurodegenerative diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 11 Biopolis Way
  • Helios, Suite 09-08
  • Singapore, 138667
  • Singapore
+65 6211 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Moleac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Mar-2008 $3.5M 00.00 Completed Generating Revenue
To view Moleac’s complete valuation and funding history, request access »

Moleac Executive Team (14)

Name Title Board Seat Contact Info
David Picard Chief Executive Officer, Board Member & Co-Founder
Kasia Kaminska Business Development Executive
Bounmy Rattanavan Board Member & Co-Founder
Daniel Cohen Co-Founder
Shun Chen Vice President & Head of Finance
You’re viewing 5 of 14 executive team members. Get the full list »

Moleac Board Members (11)

Name Representing Role Since
Bounmy Rattanavan Moleac Board Member & Co-Founder 000 0000
Christophe Polini Self Board Member 000 0000
David Picard Moleac Chief Executive Officer, Board Member & Co-Founder 000 0000
Elmar Schnee Self Chairman 000 0000
Gérard Tardy Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Moleac Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moleac Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hunza Ventures Venture Capital Minority 000 0000 000000 0
To view Moleac’s complete investors history, request access »